⌘K

Home/Filings/4/0001213900-18-005266

4//SEC Filing

Franck Amouyal 4

Accession 0001213900-18-005266

CIK 0001218683other

View on SEC.gov Company Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 11:24 AM ET

Size

5.5 KB

Accession

0001213900-18-005266

Insider Transaction Report

Form 4

Period: 2018-04-04

Wize Pharma, Inc.WIZP

Director

Transactions

Award
Stock Option (right to buy)
2018-04-04+25,000→ 0 total
Exercise: $3.59Exp: 2025-04-04→ Common Stock (25,000 underlying)

Footnotes (2)

[F1]The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.
[F2]The Stock Option was granted as compensation for services as a director of the Issuer.

Documents

1 file

4
f4040418amouyal_wizepharma.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Wize Pharma, Inc.

CIK 0001218683

Entity typeother

Related Parties

1

filerCIK 0001723469

Filing Metadata

Form type: 4
Filed: Apr 30, 8:00 PM ET
Accepted: May 1, 11:24 AM ET
Size: 5.5 KB

View on SEC.gov